Opportunity Information: Apply for RFA RR 10 001
Apply for RFA RR 10 001
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Research on Integrity in Collaborative Research (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health 93.389 National Center for Research Resources 93.989 International Research and Research Training.
- This funding opportunity was created on Dec 1, 2009 and posted on Dec 1, 2009.
- Applicants must submit their applications by Apr 7, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $850,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: County governments State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Small businesses Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Research on Integrity in Collaborative Research (R21) (Funding Opportunity Number RFA-RR-10-001) is a National Institutes of Health discretionary grant opportunity focused on improving understanding of research integrity specifically in the context of collaborative work. Issued with involvement from NCRR, FIC, NIBIB, ORI, and OHRP, the program invites institutions and organizations to propose studies examining how the relationships, structures, and day-to-day practices of collaboration shape integrity in research. The emphasis is not on general ethics training in the abstract, but on how integrity is influenced when research is conducted across teams, laboratories, institutions, disciplines, and sometimes countries, where shared responsibility, communication, and differing expectations can complicate decision-making and accountability.
The opportunity uses the NIH R21 exploratory/developmental mechanism, which is meant to support early-stage, high-potential ideas in areas where the existing evidence base is limited. In practical terms, this FOA is trying to stimulate new lines of inquiry, pilot work, and innovative approaches that can identify specific problem areas and generate data that later research can build on. Projects are expected to be exploratory but still well-justified, and they should aim to open up new understanding of why integrity can break down in collaborative environments and what conditions help prevent that from happening.
To be responsive, applications must directly address the influence of collaborative interactions and/or activities on research integrity in at least one priority area highlighted by ORI and NIH. These areas include clarifying community norms and standards (for example, how teams decide what counts as acceptable authorship, data stewardship, peer review behavior, or disclosure practices); evaluating the effectiveness of self-regulation (such as how labs, departments, professional societies, journals, or consortia enforce norms without external intervention); identifying societal, organizational, group, or individual factors that affect integrity either positively or negatively (including incentives, leadership, mentoring, power dynamics, competition, cultural differences, workload, or training); and assessing the impacts of not following accepted codes of conduct (for instance, consequences for data reliability, public trust, patient safety, team functioning, and career trajectories). Strong proposals are expected to connect these integrity questions to the realities of collaboration, such as distributed work, shared datasets, multi-site trials, cross-disciplinary standards, remote communication, or uneven oversight across partners.
The FOA also makes it clear that it is looking for work that is genuinely innovative. Proposed studies should challenge existing paradigms, be driven by an original hypothesis, or tackle major barriers that have slowed progress in understanding deviations from integrity in collaborative settings. In other words, reviewers are being cued to value projects that do more than restate known concerns; the intent is to produce sharper explanations of the multiple contributing factors behind integrity failures or successes in collaborative research and, ideally, to point toward strategies that could be tested or implemented later.
Relevance to health-related research is a requirement. Projects must have clear applicability to biomedical research, behavioral health sciences, or health services research. Applicants are also encouraged to align their chosen questions with issues that match the missions and interests of ORI or specific NIH Institutes and Centers, which signals that the program wants work that can inform real oversight, policy, and practice rather than remaining purely theoretical.
Funding for fiscal year 2010 was anticipated at $850,000 in total costs, supporting an estimated two to three new awards. The award ceiling listed is $200,000. As with many federal opportunities, awards were contingent on the availability of funds and the receipt of a sufficient number of meritorious applications. Key dates included a posted and created date of December 1, 2009, an application closing date of April 7, 2010, and an archive date of May 8, 2010.
Eligibility was broad and included many types of applicants across the public, private, nonprofit, and governmental landscape. Eligible applicants included state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofits with and without 501(c)(3) status; for-profit organizations (including small businesses and other than small businesses); public housing authorities/Indian housing authorities; Native American tribal governments (federally recognized) and tribal organizations; and additional categories such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities, faith-based or community-based organizations, U.S. territories or possessions, regional organizations, and non-U.S. (foreign) entities. The FOA also specified that there was no cost sharing or matching requirement.
Overall, this R21 opportunity is best understood as NIH and ORI encouraging the research community to take a hard, evidence-driven look at how collaboration changes the integrity landscape: where norms become unclear, where accountability becomes diffuse, what organizational and human factors predict problems or protect against them, and what the real consequences are when teams do not adhere to accepted standards. The goal is to generate new knowledge that can strengthen the culture and practice of integrity in modern, increasingly networked health research.
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled Research on Integrity in Collaborative Research (R21).
What is the Funding Opportunity Number?
The Funding Opportunity Number is RFA-RR-10-001.
Which agency is offering this grant?
This is a National Institutes of Health (NIH) discretionary grant opportunity.
Which NIH/related offices were involved in issuing the opportunity?
The FOA was issued with involvement from NCRR, FIC, NIBIB, ORI, and OHRP.
What is the main purpose of this FOA?
The FOA supports research to improve understanding of research integrity specifically in collaborative research, focusing on how relationships, structures, and day-to-day collaboration practices shape integrity.
Is this funding meant for general ethics training programs?
No. The emphasis is not on general ethics training in the abstract, but on how integrity is influenced when research is conducted across teams, laboratories, institutions, disciplines, and sometimes countries, where shared responsibility and differing expectations can complicate accountability.
What grant mechanism does this opportunity use?
It uses the NIH R21 exploratory/developmental mechanism.
What does the R21 mechanism imply about the type of projects being sought?
The R21 mechanism is intended to support early-stage, high-potential ideas in areas where the evidence base is limited. The FOA aims to stimulate new lines of inquiry, pilot work, and innovative approaches that generate data future research can build on.
What must an application do to be considered responsive?
To be responsive, applications must directly address the influence of collaborative interactions and/or activities on research integrity in at least one priority area highlighted by ORI and NIH.
What are the priority research areas highlighted by ORI and NIH in this FOA?
The priority areas include:
- Clarifying community norms and standards (e.g., authorship decisions, data stewardship, peer review behavior, disclosure practices)
- Evaluating the effectiveness of self-regulation (e.g., how labs, departments, societies, journals, or consortia enforce norms without external intervention)
- Identifying factors that affect integrity positively or negatively (e.g., incentives, leadership, mentoring, power dynamics, competition, cultural differences, workload, training)
- Assessing impacts of not following accepted codes of conduct (e.g., consequences for data reliability, public trust, patient safety, team functioning, career trajectories)
How should proposals connect integrity questions to real-world collaboration?
Strong proposals are expected to link integrity questions to the realities of collaboration such as distributed work, shared datasets, multi-site trials, cross-disciplinary standards, remote communication, and uneven oversight across partners.
How important is innovation in this FOA?
Innovation is explicitly emphasized. Proposed studies should be genuinely innovative, such as challenging existing paradigms, being driven by an original hypothesis, or addressing major barriers that have slowed progress in understanding integrity deviations in collaborative settings.
What kinds of outcomes or contributions is the FOA trying to generate?
The intent is to produce sharper explanations of the multiple contributing factors behind integrity failures or successes in collaborative research, and to point toward strategies that could be tested or implemented later.
Does the project need to be related to health research?
Yes. Relevance to health-related research is required, with clear applicability to biomedical research, behavioral health sciences, or health services research.
Should applicants align with particular NIH or ORI missions?
Applicants are encouraged to align questions with issues matching the missions and interests of ORI and/or specific NIH Institutes and Centers, signaling interest in work that can inform oversight, policy, and practice.
How much funding was anticipated for fiscal year 2010?
Total funding anticipated for FY 2010 was $850,000 in total costs.
How many awards were expected to be made?
The FOA estimated two to three new awards.
What is the award ceiling listed in the FOA?
The award ceiling listed is $200,000.
Are awards guaranteed?
No. Awards were contingent on availability of funds and on receiving a sufficient number of meritorious applications.
What were the key dates for this opportunity?
- Posted/created date: December 1, 2009
- Application closing date: April 7, 2010
- Archive date: May 8, 2010
Who was eligible to apply?
Eligibility was broad and included many public, private, nonprofit, and governmental organizations, including:
- State, county, city, township, and special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Nonprofits with and without 501(c)(3) status
- For-profit organizations (including small businesses and other than small businesses)
- Public Housing Authorities/Indian Housing Authorities
- Native American tribal governments (federally recognized) and tribal organizations
- HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities
- Faith-based or community-based organizations
- U.S. territories or possessions, regional organizations
- Non-U.S. (foreign) entities
Is cost sharing or matching required?
No. The FOA specified no cost sharing or matching requirement.
What types of collaborative settings are especially relevant to this FOA?
The FOA highlights collaboration across teams, laboratories, institutions, disciplines, and sometimes countries, where responsibility is shared and communication and expectations may differ.
What integrity topics are examples of "community norms and standards" in this FOA?
Examples include how teams define or decide what counts as acceptable authorship, data stewardship, peer review behavior, and disclosure practices.
What does "self-regulation" mean in the context of this FOA?
It refers to how entities like labs, departments, professional societies, journals, or consortia enforce norms and standards internally, without relying on external intervention.
What kinds of factors does the FOA suggest could influence integrity in collaborative research?
The FOA lists factors such as incentives, leadership, mentoring, power dynamics, competition, cultural differences, workload, and training, which may influence integrity positively or negatively.
What kinds of impacts does the FOA associate with not following accepted codes of conduct?
Examples include effects on data reliability, public trust, patient safety, team functioning, and career trajectories.
What is the overall goal of this FOA in plain terms?
The FOA aims to help the research community develop an evidence-driven understanding of where and why integrity can break down in collaborative research, what conditions protect against problems, and how this knowledge can strengthen integrity in modern, networked health research.
Browse more opportunities from the same category: Education Health
Next opportunity: Clinical Trial Planning Grants for Critical Illness and Injury in Aging (R34)
Previous opportunity: NIDCR Small Research Grants for Data Analysis and Statistical Methodology applied to Genome wide Data (R03)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA RR 10 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA RR 10 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Coordination Center for Transdisciplinary Research in Energetics and Cancer (Limited Competition U01) Apply for RFA CA 10 501 Funding Number: RFA CA 10 501 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Support Opportunity for Addiction Research (SOAR) for New Investigators (R03) Apply for RFA DA 10 015 Funding Number: RFA DA 10 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Multifunctional Drug and Gene Delivery Systems (R01) Apply for PAR 10 048 Funding Number: PAR 10 048 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cognitive Remediation Approaches to Improve Drug Abuse Treatment Outcomes (R01) Apply for RFA DA 10 006 Funding Number: RFA DA 10 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cognitive Remediation Approaches to Improve Drug Abuse Treatment Outcomes (R21) Apply for RFA DA 10 007 Funding Number: RFA DA 10 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Academic Career Award (Parent K07) Apply for PA 10 058 Funding Number: PA 10 058 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pre Application for the 2010 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 10 068 Funding Number: PAR 10 068 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| 2010 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 10 012 Funding Number: RFA DA 10 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| AIDS Malignancy Clinical Trials Consortium (Limited Competition U01) Apply for RFA CA 10 502 Funding Number: RFA CA 10 502 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanism for Time Sensitive Drug Abuse Research (R01) Apply for PAR 10 072 Funding Number: PAR 10 072 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44) Apply for RFA CA 10 009 Funding Number: RFA CA 10 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Image Guided Cancer Interventions (SBIR R43/R44) Apply for PA 10 079 Funding Number: PA 10 079 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Image Guided Cancer Interventions (STTR R41/R42) Apply for PA 10 080 Funding Number: PA 10 080 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Shared Instrumentation Grant Program (S10) Apply for PAR 10 082 Funding Number: PAR 10 082 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Systems Biology, HIV/AIDS, and Substance Abuse (R01) Apply for RFA DA 10 014 Funding Number: RFA DA 10 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| Pre Application for the 2010 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (X02) Apply for PAR 10 095 Funding Number: PAR 10 095 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| 2010 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (DP1) Apply for RFA DA 10 013 Funding Number: RFA DA 10 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for Substance Related Disorders (R01) Apply for RFA DA 10 018 Funding Number: RFA DA 10 018 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Deep Sequencing and Analysis of Pharmacogenomic Regions Discovery and Analysis of Genetic Variants Contributing to Drug Abuse and Addiction (R01) Apply for RFA DA 10 019 Funding Number: RFA DA 10 019 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Institutional Clinical and Translational Science Award (U54) Apply for RFA RM 10 001 Funding Number: RFA RM 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA RR 10 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
